Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaily Arora

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Neurocritical Care|August 3, 2013
Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patientAaron M Cook, Shaily Arora, Justin Davis, et al.
Journal of Pharmaceutical Sciences|October 2, 2013
The relative rate of immunoglobulin gamma 1 fragmentationTim J Kamerzell, Megan Li, Shaily Arora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Call to Action for Improving Oral Anticancer Agent AdherenceLaura A Levit, Shaily Arora, Paul G Kluetz, et al.
Neurocritical Care|March 13, 2015
Augmented Renal Clearance in Patients with Subarachnoid HemorrhageCasey C May, Shaily Arora, Sara E Parli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2020
FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project OrbisShaily Arora, Sanjeeve Balasubramaniam, Wei Zhang, et al.
JAMA Oncology|January 6, 2022
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration DatabaseMitchell S Anscher, Shaily Arora, Chana Weinstock, et al.
JAMA Oncology|December 29, 2022
Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021Sundeep Agrawal, Shaily Arora, Laleh Amiri-Kordestani, et al.
Journal for Immunotherapy of Cancer|July 3, 2021
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world dataKerry L Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, et al.
The Oncologist|October 5, 2020
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian CancerShaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, et al.
Leukemia & Lymphoma|June 3, 2014
Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myelomaZartash Gul, Qaiser Bashir, Martin Cremer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neurocritical Care|August 3, 2013
Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patientAaron M Cook, Shaily Arora, Justin Davis, et al.
Journal of Pharmaceutical Sciences|October 2, 2013
The relative rate of immunoglobulin gamma 1 fragmentationTim J Kamerzell, Megan Li, Shaily Arora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Call to Action for Improving Oral Anticancer Agent AdherenceLaura A Levit, Shaily Arora, Paul G Kluetz, et al.
Neurocritical Care|March 13, 2015
Augmented Renal Clearance in Patients with Subarachnoid HemorrhageCasey C May, Shaily Arora, Sara E Parli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2020
FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project OrbisShaily Arora, Sanjeeve Balasubramaniam, Wei Zhang, et al.
JAMA Oncology|January 6, 2022
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration DatabaseMitchell S Anscher, Shaily Arora, Chana Weinstock, et al.
JAMA Oncology|December 29, 2022
Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021Sundeep Agrawal, Shaily Arora, Laleh Amiri-Kordestani, et al.
Journal for Immunotherapy of Cancer|July 3, 2021
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world dataKerry L Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, et al.
The Oncologist|October 5, 2020
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian CancerShaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, et al.
Leukemia & Lymphoma|June 3, 2014
Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myelomaZartash Gul, Qaiser Bashir, Martin Cremer, et al.
Pageof 2